Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05177562

Reproductive Endocrinology Oxford Study (RepOx)

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,175 (estimated)
Sponsor
University of Oxford · Academic / Other
Sex
Female
Age
16 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This is a prospective observational study that aims to identify the underlying mechanisms of PolyCystic Ovarian Syndrome (PCOS) and associated comorbidities such as subfertility, miscarriage; and pregnancy complications such as gestational diabetes mellitus and Intrahepatic cholestasis of pregnancy (ICP). This will be achieved through cross-sectional observation and laboratory analyses.

Detailed description

Here we propose a comprehensive program to dissect the underlying disease-causing mechanisms of PCOS and associated comorbidities. We will investigate how the different layers of biological information (ranging from DNA variant genotyping, to RNA sequencing and proteomics), and clinical characteristics are correlated with each other and how this affects PCOS in fat tissue derived cells, as well as ovarian tissue and tissue derived cells by using a combination of big data analysis, a range of "-omics" technologies, of both in-house generated and publicly available data, paired with state of the art statistical and bioinformatics analysis. Out of these mechanisms and pathways we will identify druggable targets for proposals for detailed functional follow up with an aim of development of novel therapeutic options for PCOS.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThere is no intervention in this study

Timeline

Start date
2021-10-21
Primary completion
2028-09-01
Completion
2028-09-01
First posted
2022-01-04
Last updated
2022-01-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05177562. Inclusion in this directory is not an endorsement.